Archive · 28 Jun 2025
UTI Aggressive Hybrid Fund: A Value-Centric Approach
Imagine a fund that buys stocks, but only those that seem like a good deal, called "value stocks".
This fund, the UTI Aggressive Hybrid Fund, invests in a mix of stocks and bonds, aiming for growth but also stability.
It looks for companies that are undervalued by the market, hoping they will become more valuable over time.
This means the fund might not always perform the best in the short term, but it can reward patient investors in the long run.
It has a mix of stocks from different-sized companies and a focus on safe, high-quality bonds to keep risk low.
The fund's performance has varied over time, sometimes outperforming and sometimes lagging compared to other funds.
UTI Aggressive Hybrid Fund invests in undervalued companies, focusing on long-term value.
The fund typically allocates 70-72% to equities, with the remainder in debt and cash.
It employs a relative value approach, using metrics like price-to-earnings to identify undervalued stocks.
The fund's debt segment prioritizes low credit risk, primarily holding AAA-rated securities.
The fund's performance varies; it outperformed peers from 2020-2025 but lagged earlier due to its value investing strategy.
- Who
- The UTI Aggressive Hybrid Fund and its investors.
- What
- UTI Aggressive Hybrid Fund's investment strategy and performance.
- When
- Published on June 28, 2025; analyzing fund performance over the last 10 years.
- Where
- Not explicitly mentioned in the article.
- Why
- The fund aims to provide long-term returns by investing in undervalued companies and a mix of assets.
Value Investing
Growth Investing
Investment Strategy
Value Investing
Favors undervalued companies, emphasizing long-term growth and requiring investor patience.
Growth Investing
May lag behind growth or momentum strategies in the short term, leading to periods of underperformance.
- Equity Allocation
- 70-72%
- Debt Allocation
- 23-25%
- Cash Allocation
- Approx. 2%
- 10-Year Return
- 12.3% (vs. Category Average 11.7%)
- Regular Plan Expense Ratio
- 1.9%
- Direct Plan Expense Ratio
- 1.2%